Giamarellos-Bourboulis, Evangelos J.
Funding for this research was provided by:
University of Athens
Article History
Received: 14 August 2023
Accepted: 24 October 2023
First Online: 15 November 2023
Change Date: 1 December 2023
Change Type: Update
Change Details: A note on the supplement has been added after the conflict of interest.
Declarations
:
: E.J. Giamarellos-Bourboulis has received honoraria from Abbott Products Operations AG, bioMérieux, Brahms GmbH, GSK, InflaRx GmbH, Sobi and Xbiotech Inc; independent educational grants from Abbott Products Operations AG, bioMérieux Inc, InflaRx GmbH, Johnson & Johnson, MSD, Sobi and Xbiotech Inc. and funding from the Horizon 2020 Marie Skłodowska-Curie International Training Network “the European Sepsis Academy” (granted to the National and Kapodistrian University of Athens), the Horizon 2020 European Grants ImmunoSep and RISCinCOVID and the Horizon Health grant EPIC-CROWN‑2 (granted to the Hellenic Institute for the study of sepsis).
: This is a review article and there was no need for Ethics approval.
: The supplement containing this article is not sponsored by industry.